Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms

Mycoses

Volumn 56, Issue 6, 2013, Pages 672-680

  Monteiro, Douglas R ^a,b   Silva, Sónia ^b   Negri, Melyssa ^b,c   Gorup, Luiz F ^d   de Camargo, Emerson R ^d   Oliveira, Rosário ^b   Barbosa, Debora B ^a   Henriques, Mariana ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

^c Faculty of Medicine   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Candida biofilms; Chlorhexidine digluconate; Nystatin; Silver nanoparticles; Synergism

Indexed keywords

CHLORHEXIDINE GLUCONATE; CRYSTAL VIOLET; NYSTATIN; PERIO AID; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FUNGAL BIOMASS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TREATMENT DURATION;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

CANDIDA BIOFILMS; CHLORHEXIDINE DIGLUCONATE; NYSTATIN; SILVER NANOPARTICLES; SYNERGISM;

ANTISEPSIS; BIOFILMS; CANDIDA ALBICANS; CANDIDA GLABRATA; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; DISINFECTANTS; DRUG SYNERGISM; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NYSTATIN; SILVER; SPECTROPHOTOMETRY;

EID: 84886248364     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12093     Document Type: Article

References (25)

1. Silva S, Henriques M, Hayes A, Oliveira R, Azeredo J, Williams DW. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med 2011; 40: 421-7.
2. Chandra J, Mukherjee PK, Leidich SD et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001; 80: 903-8.
3. Watamoto T, Samaranayake LP, Jayatilake JA, Egusa H, Yatani H, Seneviratne CJ. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Int J Antimicrob Agents 2009; 34: 333-9.
4. Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 2008; 23: 377-83.
5. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000; 11: 172-98.
6. Ryalat S, Darwish R, Amin W. New form of administering chlorhexidine for treatment of denture-induced stomatitis. Ther Clin Risk Manag 2011; 7: 219-25.
7. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 2009; 34: 103-10.
8. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009; 27: 76-83.
9. Monteiro DR, Gorup LF, Takamiya AS, de Camargo ER, Filho AC, Barbosa DB. Silver distribution and release from an antimicrobial denture base resin containing silver colloidal nanoparticles. J Prosthodont 2012; 21: 7-15.
10. Monteiro DR, Gorup LF, Silva S et al. Silver colloidal nanoparticles: antifungal effect against Candida albicans and Candida glabrata adhered cells and biofilms. Biofouling 2011; 27: 711-9.
11. Monteiro DR, Silva S, Negri M et al. Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms. Lett Appl Microbiol 2012; 54: 383-91.
12. Carlson C, Hussain SM, Schrand AM et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008; 112: 13608-19.
13. Gorup LF, Longo E, Leite ER, Camargo ER. Moderating effect of ammonia on particle growth and stability of quasi-monodisperse silver nanoparticles synthesized by the Turkevich method. J Colloid Interface Sci 2011; 360: 355-8.
14. Lamfon H, Porter SR, McCullough M, Pratten J. Formation of Candida albicans biofilms on non-shedding oral surfaces. Eur J Oral Sci 2003; 111: 465-71.
15. Miceli MH, Bernardo SM, Lee SA. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 2009; 34: 326-32.
16. Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology 2010; 98: 15-25.
17. Olsen I. Denture stomatitis. The clinical effects of chlorhexidine and amphotericin B. Acta Odontol Scand 1975; 33: 47-52.
18. Cross LJ, Williams DW, Sweeney CP, Jackson MS, Lewis MA, Bagg J. Evaluation of the recurrence of denture stomatitis and Candida colonization in a small group of patients who received itraconazole. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 351-8.
19. Wei GX, Xu X, Wu CD. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. Arch Oral Biol 2011; 56: 565-72.
20. Samaranayake YH, Ye J, Yau JY, Cheung BP, Samaranayake LP. In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 2005; 43: 818-25.
21. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP. Proteomics of drug resistance in Candida glabrata biofilms. Proteomics 2010; 10: 1444-54.
22. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 2008; 72: 157-65.
23. Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiol Lett 1992; 79: 211-5.
24. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2005; 5: 244-9.
25. Tas J, Westerneng G. Fundamental aspects of the interaction of propidium diiodide with nuclei acids studied in a model system of polyacrylamide films. J Histochem Cytochem 1981; 29: 929-36.